Plasma amino acids is a screening test done on infants that looks at the amounts of amino acids in the blood. Amino acids are the building blocks for proteins in the body.
Most of the time, blood is drawn from a vein located on the inside of the elbow or the back of the hand.
In infants or young children, a sharp tool called a lancet may be used to puncture the skin.
The blood sample is sent to a lab. There are several types of methods used to determine the individual amino acid levels in the blood.
The person having the test should not eat 4 hours before the test.
There might be slight pain or a sting when the needle is inserted. You may also feel some throbbing at the site after the blood is drawn. The needle stick will probably cause an infant or child to cry.
This test is done to measure the level of amino acids in the blood.
An increased level of a particular amino acid is a strong sign. This shows that there is a problem with the body's ability to break down (metabolize) that amino acid.
The test may also be used to look for decreased levels of amino acids in the blood.
Increased or decreased levels of amino acids in the blood may occur with fevers, inadequate nutrition, and certain medical conditions.
All measurements are in micromoles per liter (µmol/L). Normal values may vary between different laboratories. Talk to your health care provider about your specific test results.
The examples above show the common measurements for results for these tests. Some laboratories use different measurements or may test different specimens.
An increase in the total level of amino acids in the blood may be due to:
A decrease in the total level of amino acids in the blood may be due to:
High or low amounts of individual plasma amino acids must be considered with other information. Abnormal results may be due to diet, hereditary problems, or effects of a medicine.
Screening infants for increased levels of amino acids can help detect problems with metabolism. Early treatment for these conditions may prevent complications in the future.
Reviewed By: Anna C. Edens Hurst, MD, MS, FACMG, Assistant Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.